New Novartis R&D centre in China
Fabrice Martin
Swiss pharmaceutical lab company Novartis announced its 8th R&D centre in Shanghaï, China.Mainly dedicated to research on infectious causes of prevalent cancers in China, this centre represents a USD 100 million investment. By establishing its new centre, which should employ more than 400 researchers by 2008, at the Zhangjiang Hi-Tech Park, near Shanghaï, Novartis bets on the development of this emerging life science cluster.
Operations are set to begin in May 2007.
More information about ABG?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
ANRT 
PhDOOC 
MabDesign 
ASNR - Autorité de sûreté nucléaire et de radioprotection - Siège 
Aérocentre, Pôle d'excellence régional 
Groupe AFNOR - Association française de normalisation 
SUEZ 
Tecknowmetrix 
CASDEN 
Laboratoire National de Métrologie et d'Essais - LNE - MabDesign
Généthon 
ADEME 
TotalEnergies 
Ifremer 
Nokia Bell Labs France 
CESI 
Institut Sup'biotech de Paris 
ONERA - The French Aerospace Lab
